Pivot secures $32M in Series C

Sunnyvale, CA-based Pivot Medical has raised $32 million in a Series C round led by new investor Adams Street Partners. Delphi Ventures also participated, as well as founding investor Montreux Equity Partners and existing investor Ivy Capital Partners.

The company will use the funds for the commercial rollout of its Pivot hip arthroscopy system in the U.S. and Europe and to expand its clinical research programs. The system was designed make hip arthroscopy safer, more efficient and easier for physicians to perform, according to a company statement.

"Pivot Medical was founded to deliver new technologies that dramatically advance the field of minimally invasive hip restoration, and we are meeting this commitment with a comprehensive line of innovative, highly differentiated products that will enable physicians to successfully treat their hip pain patients while preserving the delicate and complex hip anatomy," said Jack Giroux, president and CEO of Pivot.

- get more from the Pivot Medical release

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.